ASTRAZENECA DEPLOYS CARE ACCESS RESEARCH TOOL FOR COVID-19 TREATMENT CLINICAL TRIAL
HIGHLIGHTS AstraZeneca and Care Access Research have forged a partnership to support the Phase III clinical trial for AZD7442. AZD7442 has been developed by AstraZeneca as an attempt to prevent COVID-19. AZD7442 is a monoclonal antibody combination. Participants for this…